香港股市 將在 2 小時 10 分鐘 開市

健倍苗苗 (2161.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
1.040-0.010 (-0.95%)
收市價: 03:43PM HKT

健倍苗苗

Unit 2303-07, Tower 1
23rd Floor, Millennium City 1 388 Kwun Tong Road
Kwun Tong
Hong Kong
852 2267 2178
http://www.jbmhealthcare.com.hk

版塊Healthcare
行業Drug Manufacturers—Specialty & Generic
全職員工274

高階主管

名稱標題支付行使價出生年份
Mr. Yat Wai WongCEO & Exec. Director1964
Mr. Kau Lap LamGroup Financial Controller1987
Ms. Man Yee AuCOO & Company Sec.1973
Ms. Chui Yee LoSr. Marketing Mang.1969
Dr. Ka Wing ChuExec. Director & Pres of the Proprietary Chinese Medicine Bus.1973
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

JBM (Healthcare) Limited, an investment holding company, develops, manufactures, markets, distributes, and sells healthcare and wellness products in Asia. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices; and pharmaceutical products. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.

公司管治

截至 無 止,健倍苗苗 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。